HIGHLIGHTS
- who: Jason Shafrin from the GlaxoSmithKline plc, Collegeville, PA, USA have published the Article: Economic burden of antibiotic-not-susceptible isolates in uncomplicated urinary tract infection: Analysis of a US integrated delivery network database, in the Journal: (JOURNAL) of 31/03/2020
- what: One of the primary goals of treating a uUTI is to achieve rapid symptom relief and, therefore, a short course of antibiotic treatment is the preferred option . This study reports a comparison of the economic burden for female patients with uUTI with isolates that were either susceptible or not-susceptible to the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.